Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine and atropine for prevention of post-dural puncture headache after spinal anesthesia in cesarean section
IRCT20210324050762N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2021
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of neostigmine and atropine in post-dural puncture headache (PDPH) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of headache and Duration of headache. Started Aug 2021; status: completed.
02
Drugs
neostigmineatropine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20210324050762N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210324050762N1.